# Lack of Bridge to Recovery in Pediatric Dilated Cardiomyopathy With Left Ventricular Noncompaction

**Authors:** Moyu Hasegawa, Masaki Taira, Yuji Tominaga, Takuji Watanabe, Yosuke Kugo, Toshiaki Nagashima, Akima Harada, Takayoshi Ueno, Shigeru Miyagawa

PMC · DOI: 10.1016/j.atssr.2024.02.021 · 2024-08-22

## TL;DR

This study found that children with a specific heart condition called left ventricular noncompaction do not benefit from a heart pump treatment as much as others.

## Contribution

The study is the first to show that left ventricular noncompaction worsens recovery outcomes with the Berlin Heart EXCOR in pediatric patients.

## Key findings

- No cardiac recovery was observed in patients with left ventricular noncompaction.
- Patients without noncompaction had a 55% recovery rate with the Berlin Heart EXCOR.
- Myocardial fibrosis was significantly higher in the noncompaction group.

## Abstract

This study assessed the possibility of a bridge to recovery using the Berlin Heart EXCOR and the histologic characteristics of pediatric patients with dilated cardiomyopathy accompanied by a left ventricular noncompaction phenotype.

Of the 17 pediatric patients with dilated cardiomyopathy who underwent Berlin Heart EXCOR implantation between 2013 and 2020, 6 were diagnosed with left ventricular noncompaction association. The patients were classified into 2 groups: the dilated cardiomyopathy group and dilated cardiomyopathy with the left ventricular noncompaction phenotype group. The histologic characteristics of the left ventricular myocardium and left ventricular function after Berlin Heart EXCOR implantation were compared.

Cardiac recovery was not observed in the dilated cardiomyopathy with left ventricular noncompaction group. In contrast, 6 patients (55%) in the dilated cardiomyopathy group achieved cardiac recovery, and the Berlin Heart EXCOR was explanted. The degree of myocardial fibrosis was significantly higher in the dilated cardiomyopathy with the left ventricular noncompaction phenotype group than in the dilated cardiomyopathy group (P < .05). The final follow-up left ventricular ejection fraction and end-diastolic diameter during Berlin Heart EXCOR support improved significantly compared with the preimplantation variables in the dilated cardiomyopathy group (both P < .001); the dilated cardiomyopathy with left ventricular noncompaction phenotype group showed no improvements (P = .84 and P = .37, respectively).

The left ventricular noncompaction phenotype associated with dilated cardiomyopathy may adversely affect the rate of cardiac recovery with Berlin Heart EXCOR.

## Linked entities

- **Diseases:** dilated cardiomyopathy (MONDO:0005021), left ventricular noncompaction (MONDO:0018901)

## Full-text entities

- **Diseases:** myocardial fibrosis (MESH:D005355), left ventricular (MESH:D018487), Left Ventricular Noncompaction (MESH:C565821), Dilated Cardiomyopathy (MESH:D002311)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11910776/full.md

---
Source: https://tomesphere.com/paper/PMC11910776